Cargando…

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients

Cell division cycle associated 2(CDCA2) is overexpressed in neuroblastoma and oral squamous cell carcinoma, and its overexpression positively correlates to tumor progression. However, the biological and clinical significance of CDCA2 in lung adenocarcinoma(LAC) has never been investigated. We determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Run, Zhang, Chunrong, Wu, Yaqin, Wang, Xin, Sun, Qi, Sun, Jing, Xia, Wenjie, Dong, Gaochao, Wang, Anpeng, Jiang, Feng, Xu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386720/ https://www.ncbi.nlm.nih.gov/pubmed/28423619 http://dx.doi.org/10.18632/oncotarget.15519

Ejemplares similares

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

The TWIST1-centered competing endogenous RNA network promotes proliferation, invasion, and migration of lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2019)

The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma
por: Wang, Anpeng, et al.
Publicado: (2021)

SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma
por: Huang, Jun, et al.
Publicado: (2016)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

A network-based signature to predict the survival of non-smoking lung adenocarcinoma
por: Mao, Qixing, et al.
Publicado: (2018)

Improvement of survival for non-small cell lung cancer over time
por: Xia, Wenjie, et al.
Publicado: (2017)

CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma
por: Gu, Jichun, et al.
Publicado: (2022)

DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2015)

CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway
por: Feng, Sitong, et al.
Publicado: (2023)

Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma
por: Wang, Zaiyan, et al.
Publicado: (2021)

ADFP promotes cell proliferation in lung adenocarcinoma via Akt phosphorylation
por: Meng, Xia, et al.
Publicado: (2020)

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma
por: Wei, Dong, et al.
Publicado: (2023)

UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells
por: Liu, Zhi, et al.
Publicado: (2018)

MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma
por: Hu, Zhan-Dong, et al.
Publicado: (2019)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma
por: Zhang, Pei-pei, et al.
Publicado: (2017)

Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma
por: Liang, Yingkuan, et al.
Publicado: (2020)

TGFBI Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Seok, Yangki, et al.
Publicado: (2019)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients
por: Liu, Shuguang, et al.
Publicado: (2014)

HOXC10 Promotes the Metastasis of Human Lung Adenocarcinoma and Indicates Poor Survival Outcome
por: Tang, Xiao-Lei, et al.
Publicado: (2017)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
por: He, Jian, et al.
Publicado: (2023)

Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma
por: Zhang, Te, et al.
Publicado: (2020)

Clinical and prognostic implications of an immune‐related risk model based on TP53 status in lung adenocarcinoma
por: Song, Xuming, et al.
Publicado: (2021)

Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma
por: Li, Dong, et al.
Publicado: (2020)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

Integrative analysis of differential genes and identification of a “2‐gene score” associated with survival in esophageal squamous cell carcinoma
por: Wang, Lin, et al.
Publicado: (2018)

Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma
por: Chang, Chao-Yuan, et al.
Publicado: (2022)

Lower Expression of TWEAK is Associated with Poor Survival and Dysregulate TIICs in Lung Adenocarcinoma
por: He, Zhengxi, et al.
Publicado: (2022)

GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma
por: Wei, Xing, et al.
Publicado: (2018)

Retraction: HOXC10 promotes the metastasis of human lung adenocarcinoma and indicates poor survival outcome
Publicado: (2023)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

Long non-coding RNA, CHRF, predicts poor prognosis of lung adenocarcinoma and promotes cell proliferation and migration
por: Xie, Xiaowei, et al.
Publicado: (2018)

Functional role of RBM10 in lung adenocarcinoma proliferation
por: Sun, Xiuna, et al.
Publicado: (2018)

FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023)

SKA3 Up-regulation Promotes Lung Adenocarcinoma Growth and is a Predictor of Poor Prognosis
por: Sun, Rong-Li, et al.
Publicado: (2019)

NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma
por: Zhan, Ping, et al.
Publicado: (2016)

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
por: Yang, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgh2nobkl357ejjguo8bap7dlj